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                                                 ABBREVIATIONS 
 
CBC   - Complete blood count    
CRP   - C-reactive protein 
 CT   - Computer tomography    
CTA   - CT angiography  
DUS   - Duplex ultrasound scan  
DWI   - Diffusion weighted imaging  
FDA   - Food and drug administration 
ICA   - Internal carotid artery  
IMT   - Intima media thickness  
LACI             -          Lacunar infarct  
MCA   - Middle cerebral artery  
MES   - Microembolic signals 
MR   - Magnetic resonance 
MRA   - MR angiography 
MRI   - Magnetic resonance imaging  
mRS   - Modified Rankin Scale  
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NIHSS  - National Institutes of Health Stroke Scale 
NINDS  - National Institutes of Neurological Disorders and Stroke 
OCSP  - Oxfordshire Community Stroke Project  
PACI   - Partial anterior circulation infarct 
POCI   - Posterior circulation infarct  
SITS  - MOST SITS-Monitoring Study  
TACI   - Total anterior circulation infarct  
TCD   - Transcranial Doppler T 
CCD   - Transcranial colour coded Doppler 
TEE   - Transoesophageal echocardiography  
TIA   - Transient ischemic attack  
TOF  -  Time of flight  
MRA   -  Magnetic resonance angiography 
TOAST  - Trial of Org 10172 in Acute Stroke Treatment  
tPA   - Tissue plasminogen activator 
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INTRODUCTION 
 
            Stroke is defined as rapidly developing clinical signs due to focal disturbance  
 of cerebral function lasting for more than 24 hours or leading to death with no  
 apparent cause other than vascular origin. 
            Cerebrovascular disease is the leading cause of death throughout the world. 
 Stroke is classified into two main types – ischemic and hemorrhagic stroke. Ischemic  
stroke accounts for about 63% of all cases and is due to the obstruction of the blood  
vessel by a thrombus or emboli. 
 
Modifiable Risk Factors 
 Diabetes 
 Hypertension 
 Atrial fibrillation 
 Smoking etc., 
 The realisation that atherosclerosis thus stroke is an inflammatory disease has  
led to the search of new risk factors. The markers of inflammation like CRP, ICAM-1,  
phospholipase a2, wbc count, interleukins, e nos, homocysteine, RAS, fibrinogen,  
Lp a, TGF, infectious agents like Chlamydia, CMV, H pylori have been proposed as  
new risk factors for stroke. One more addition to the list is micro albuminuria. 
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 Micro albuminuria is defined as urinary excretion of albumin 20- 
200mcg/mg  creatinine in early morning urine sample. 
 Micro albuminuria is a strong marker of endothelial damage, is proven to  
have an association with ischemic stroke. 
 Thus estimating micro albuminuria by simple non-invasive dipstick  
procedure will be new addition to the long list of risk factors of stroke and by  
treating it incidence of stroke might be decreased. 
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                                 AIM AND OBJECTIVES 
 
To determine the presence of  micro albuminuria in non-diabetic ischemic  
 
stroke patients and proving micro albuminuria as an independent risk factor. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                            
 
                                  REVIEW ON LITERATURE
 Cerebrovascular accident is the seco
The incidence of cerebrovascular accident increases with age 
stroke is projected to increase as the elderly population grows.
There are two main type of stroke :
1. Hemorrhagic stroke 
 
2. Ischemic stroke 
 
Ischemic stroke is the major type of  stroke  constitutes 50
stroke is  occlusion of blood vessels by thrombi or emboli
Hemorrhagic stroke is due to rupture of blood vessels
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nd leading cause of death worldwide. 
,and the number of 
 
 
- 75%.  Isc
. 
 
 
hemic  
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Types 
 
Percentage 
Cerebral infarction  
 
 
Large vessel occlusion 
 
50 
Small vessel (lacunar) infarcts 
 
25 
Cardiac emboli 
 
15 
Blood disorders 
 
5 
Vasculitis 
 
5 
Primary ICH  
 
 
Hypertensive bleeds 
 
60 
Amyloid angiopathy 
 
20 
Vascular malformations 
 
15 
Bleeding diathesis 
 
5 
Non traumatic SAH  
 
 
Aneurysms 
 
80 
Vascular malformations 
 
10 
Non aneurysmal SAH 
 
10 
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DEFNITIONS 
 Stroke is defined as an abrupt onset of neurological deficit that is  
attributable to a focal vascular cause. 
 TRANSIENT ISCHEMIC ATTACKS 
 TIA is defined when all neurological signs and symptoms resolve within 
 24 hours without evidence of brain infarction on brain imaging.  
STROKE 
          Stroke has occurred if neurological signs and symptoms last for more  
than 24 hours or brain infarction is demonstrated.  
STROKE IN EVOLUTION 
         Stroke in Evolution is a progressive neurological deficit developing over few  
hours or days, which evolves to Completed stroke after a few hours or days.  
COMPLETED STROKE 
             Completed Stroke is a stroke syndrome in which the deficit is prolonged and  
often permanent causing demonstrable parenchymal damage and does not progress  
beyond 96 hrs 
REVERSIBLE ISCHEMIC NEUROLOGICAL DEFICIT 
            Neurological deficit resolves  within 1-3 weeks 
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EPIDEMIOLOGY  
Stroke is one of the leading cause of morbidity in adults worldwide. 
The morbidity and mortality associated with stroke are 
 
a) Global.  400-800 strokes per 1oo,ooo 
  
b) 5.7 million deaths 
 
c) 16 million new acute stroke every year  
 
d) Disability adjusted life year (DALYS) around 28 lakhs 
 
e) 4 week case fatality rate ranges from 18% - 36% 
 
INDIA  
a) Prevalence 90- 222 per 100,000 
 
b) 102,620 million deaths. 
 
c) In each year the incidence of strokes cases were 1.4 to 1.6 million  
 
d) 6,398,000 DALYs 
 
e) The incidence of stroke below 40 years were around 12%. 
 
f) 4 week case fatality rate ranges from 17%- 36% 
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PATHOPHYSIOLOGY OF ISCHEMIC STROKE 
 Arterial occlusion of an intracranial vessel causes reduction in blood flow  
to the brain. The magnitude of flow reduction depends on 
a- Collateral blood flow 
 
b- Site of occlusion 
 
c- Systemic blood pressure 
 
Blood flow Time 
 
Results 
0 4-10mins 
 
Brain death 
<16-18/min 1 hour 
 
Infarction 
<20ml/min Several hours or days 
 
Ischemia 
 
 Cerebral infarction occurs via two pathways 
 
1. Necrotic pathway 
 
• Ischemia – decreased glucose and oxygen to neurons – failure of  
 
mitochondria to produce ATP- membrane ion pumps stop 
 
 functioning – calcium influx – proteolysis – cell death 
 
• Arterial occlusion – increased extracellular glutamate  -  
 
Neurotoxicity 
 
• Mitochondrial dysfunction also releases free radicals – destruction  
 
of neurons 
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2. Apoptotic pathway  :  
 
 Lesser degrees of ischemia favour apoptotic pathway where cells die  
 
days to weeks later 
 
     Fever and hyper glycemia are important risk factors for stroke, so must be avoided 
. 
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CLASSIFICATION 
 
1. Oxfordshire classification 
 
o Anterior circulation syndrome (total)  
 
Anterior and Middle cerebral artery 
 
o Anterior circulation syndrome (partial) 
 
o Lacunar syndrome (small vessel) 
 
o Posterior  circulation syndrome 
 
 
2. Hachinske and Norris classification 
 
A. Presumed stroke 
 
Presumed TIA  
 
B. Anatomic classification 
 
a. By vascular supply  -  Carotid   
 
Vertebro basilar 
 
b. By location 
 
Supra tentorial   Lobar 
 
     Ganglionic/thalamic 
 
Infra tentorial             Cerebellar 
 
      Brainstem 
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C. Etiological classification 
 
a. By result 
 
Cerebral infarct  - Arterial 
 
                           Arteriolar 
 
    Venous 
 
Cerebral haemorrhage Parenchymal 
 
    Subarachnoid 
 
 
 
 
 
 
b. By cause 
  
Ischaemia   Embolism 
 
    Extracranial 
 
Haemorrhage             Hypertension 
 
              Amyloid angiopathy 
 
    Vascular malformation 
 
    Aneurysm 
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ETIOLOGY OF ISCHEMIC STROKE 
 
COMMON 
 
UNCOMMON 
 
Thrombosis 
 
Lacunar stroke 
 
Large Vessel thrombosis 
 
Dehydration 
 
Embolic occlusion 
 
Arterial dissection 
 
Cardio embolic 
 
Atrial fibrillation 
 
Dilated cardiomyopathy 
 
MI 
 
Mitral stenosis 
 
Infective endocarditis 
Protein C, protein S deficiency 
 
Factor V leiden mutation 
 
Anti thrombin deficiency 
 
APLA, SLE 
 
Malignancies 
 
Sickle cell anemia, Beta thalassemia 
 
Polycythemia vera 
 
Homocysteinemia 
 
TTP 
 
OCPs 
 
Nephrotic syndrome 
 
DIC 
 
Venous sinus thrombosis 
 
Fibro muscular dysplasia 
 
Vasculitis 
 
Atrial myxomas 
 
Drugs – cocaine, amphetamine 
 
Moya moya disease 
 
Eclampsia 
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RISK FACTORS 
 Old age 
 
 Male gender 
 
 Hypertension 
 
 Smoking 
 
 Increase Lipoprotein a 
 
 Diabetes 
 
 Hypercoagulable states 
 
 Atrial fibrillation 
 
 Alcohol 
 
 Increased salt intake 
 
 Vascular diseases – CAD,PVD 
 
 Hereditary syndromes – Marfan, Ehler Danlos, Fibro muscular dysplasia 
 
 Pseudo xantoma elasticum, Sickle cell disease, Fabry disease 
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CLINICAL FEATURES 
 
 In  transient ischemic attack,  symptoms of stroke are resolved within 24  
 
hours. 
 
 ABCD2 score is useful in predicting the short-term stroke risk after a TIA 
 
A = Age 
 
 B = Blood pressure  
 
C = Clinical symptoms 
 
 D = Duration of symptoms  
 
 D = Diabetes. 
 
Age >60 -Yes                                                                                         +1 
 
BP > 140/90 mmHg at initial evaluation -Yes                                   +1  
 
Clinical features of TIA:  
 
Unilateral weakness                                                                              +2  
 
Speech disturbance without weakness                                                  +1  
 
Duration of symptoms 
 
 10-59mins                                                                                             +1  
 
Over 60 mins                                                                                         +2  
 
Diabetes mellitus in patient’s history?- Yes                                          +1 
 
 HIGH RISK – score of 4 or above. Within 24 hrs consult TIA clinic 
 
 LOW RISK – any score of 3 or under 3. Within 7 days consult TIA clinic  
 
 MCA TERITORY 
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 MIDDLE CEREBRAL ARTERY INFARCT 
 
1) Paralysis of contra lateral face ,arm ,leg and sensory impairment over   
     same area- Somatic motor and sensory area 
2) Motor aphasia  - Motor area of dominant hemisphere 
 
3) Acalculia, alexia, finger agnosia , right left confusion    
                      (gestermann syndrome ) –Dominant parieto occipital lobe 
4) Apraxia ,- non dominant parietal lobe 
 
5) Homonymous hemi anopia -  Optic radiation 
 
6) Paralysis of conguate vision to opposite side – Frontal eye field 
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ACA TERRITORY 
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ANTERIOR CEREBRAL ARTERY INFARCT 
 
a) Paralysis of opposite site toes ,foot, leg and sensory loss over same area  
 
Motor leg area and Sensory area respectively 
 
b) Urinary incontinence – Para central lobule 
 
c) C/l grasp ,sucking, gegenhalten reflex –Medial surface of posterior    
 
frontal lobe 
 
d) Gait apraxia – Frontal cortex 
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                           PCA TERRITORY 
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POSTERIOR CEREBRAL ARTERY  
 
 
P1 SYNDROMES 
SYNDROMES CLINICAL 
 
FEATURES 
 
STRUCTURES 
INVOLVED 
Claude Cerebellar ataxia- 
 
crossed and I/L third 
 
nerve palsy 
 
Red nucleus or 
 
Dentate rubro thalamic 
 
tract 
Weber C/L hemiplegia, I/L 
 
third nerve palsy 
 
Cerebral peduncle 
Benedict C/L rubral tremor + C/L 
 
Hemiplegia+ III nerve 
 
palsy 
 
Red nucleus with 
 
cerebral 
 
peduncle 
Dejerine Roussy 
 
Syndrome 
 
C/L hemi sensory loss Thalamus 
Sub thalamus C/L hemi ballismus 
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P2 SYNDROMES 
 
SYNDROMES CLINICAL FEATURES STRUCTURES 
 
INVOLVED 
 
Antons syndrome 
 
Cortical blindness B/L occipital lobe 
Balints syndrome Asimultagnosia and 
 
Palinopsia 
 
B/L visual association 
 
area 
Occipital lobe C/L homonymous 
 
hemianopia with 
 
macular sparing 
 
 
Medial temporal lobe Memory impairment 
 
 
 Visual hallucination 
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AXIAL SECTION AT THE LEVEL OF MEDULLA 
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MEDIAL MEDULLARY SYNDROME 
 
1. On the side of lesion  - Paralysis with atrophy of one half of the tongue –  
 
I/L XII nerve 
 
2. On the opposite side – Paralysis of arm and leg sparing face, impaired  
 
tactile and proprioceptive sense – C/L pyramidal tract and medial 
 
 leminiscus 
 
LATERAL MEDULLARY SYNDROME 
 
1.  On the side of lesion – 
 
A) Pain, numbness and impaired sensation over  one half of the face – 
 
 Descending tract of V nerve. 
 
B) Nystagmus , vertigo – Vestibular nucleus 
 
C) Dysphagia, hoarseness, paralysis of palate and vocal cord – IX and X  
 
Nerves 
 
D) Loss of taste – NTS  
 
E) Ataxia –Cerebellar hemisphere 
 
F) Weakness of lower face – UMN facial palsy 
 
G) I/L numbness of arm, tongue or leg – Cuneate and gracile nucleus 
 
2. On the opposite side of lesion – impaired pain and temperature –  
 
Spino thalamic tract. 
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             AXIAL SECTION AT INFERIOR PONS 
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MEDIAL INFERIOR PONTINE SYNDROME 
 
On side of lesion –  
 
A) Paralysis of conjugate gaze – centre for conjugate gaze 
 
 B) Nystagmus – vestibular nucleus 
 
 C) Ataxia – middle cerebellar peduncle 
 
 D) Diplopia on lateral gaze 
 
On opposite side of lesion – 
  
A) Paralysis of face, arm and leg – Corticobulbar and corticospinal tract 
 
B) Impaired touch and proprioception – Medial lemniscus 
      
LATERAL INFERIOR PONTINE SYNDROME – AICA 
 
On the side of the lesion –  
 
A) Nystagmus , vertigo – Vestibular nerve 
 
B)Facial paralysis – VII nerve 
 
C)Paralysis of conjugate gaze – Centre for conjugate gaze 
 
D)Deafness and tinnitus – Auditory or cochlearnucle 
 
E)Ataxia- Middle cerebellar peduncle 
 
F) Impaired sensation over face – V nerve 
 
On opposite side –  
 
Impaired pain and temperature – Spino thalamic tract. 
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                   AXIAL SECTION AT MID PONS 
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MEDIAL MIDPONTINE SYNDROMES 
 
On the side of lesion – Ataxia of limbs  - Pontine nuclei 
 
On the opposite side – 
 
A) Paralysis of face, arm and legs – Cortico bulbar and Cortico spinal 
 
B) Impaired touch and proprioception – Medial Leminiscus 
 
 
       
LATERAL MIDPONTINE SYNDROMES 
 
On the side of lesion – 
  
A) Ataxia – Middle Cerebellar peduncle 
 
C) Paralysis of muscles of mastication – Motor fibres of V nerve 
 
C) Impaired sensation over face – Sensory Fibres of V Nerve 
 
Opposite side  - 
 
A) Impaired pain and temperature on limbs – Spino thalamic tract. 
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                             AXIAL SECTION AT SUPERIOR PONS 
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MEDIAL SUPERIOR PONTINE SYNDROME 
 
On the side of the lesion –  
 
 A)Cerebellar ataxia –  Superior and middle cerebellar peduncle 
 
B) Internuclear ophthalmoplegia – Medial longitudinal fasciculus 
 
C) Myoclonic syndrome  
 
On opposite side of the lesion –  
 
A) Paralysis of face, arm , leg- Cortico bulbar and Cortico spinal 
  
B) Touch and proprioception impaired – Medial leminiscus 
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LATERAL SUPERIOR PONTINE SYNDROME 
 
On the side of lesion –  
 
A)  Ataxia – Middle and superior cerebellar peduncles 
           B) Nystagmus and vertigo  - Vestibular nucleus 
           C) Paralysis of conjugate gaze – Gaze centre 
           D) Skew deviation 
           E) Horner s syndrome – Descending sympathetic fibres 
           F) Tremor – Dentate nucleus 
           On the opposite side of lesion - 
            A) Impaired pain and temperature –Spino thalamic tract 
B) Impaired touch and proprioception – Medial leminiscus 
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                           AXIAL SECTION AT  MIDBRAIN LEVEL 
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MEDIAL MIDBRAIN SYNDROME  
On side of lesion – Eyes down and out – IV and VI nerves – Unopposed action 
On opposite side – paralysis of face, arms and legs – Corticospinal and corticobulbar  
Tract 
LATERAL MIDBRAIN SYNDROME 
On side of lesion - Eyes down and out – IV and VI nerves – Unopposed action 
On opposite side – hemiataxia, tremors – Red nucleus 
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INVESTIGATIONS 
 
1. CT scan – To differentiate between infarct and hemorrhage 
To rule out other conditions mimicking stroke like neoplasm, abscess 
2. MRI scan – To know the size of infracted area 
 
3. Diffusion weighted imaging  - early diagnosis of infarct 
 
4. MRI arteriography – confirmatory investigation for detecting stenosis,  
 
vasospasm, fibro muscular dysplasia, intramural thrombi and collaterals. 
 
5. Carotid artery Doppler  
 
6. MRI perfusion technique – can identify ischemic penumbra. Ischemic  
 
penumbra helps in selection of patients who may benefit from acute  
 
intervention like thrombolysis. 
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CT BRAIN showing  INFARCT 
 
 
 
 
CT BRAIN  showing HEMORRHAGE 
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  DIFFUSION WEIGHTED MRI SHOWING INFARCT 
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MRI PERFUSION SHOWING EFFECT OF THROMBOLYSIS 
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            TREATMENT 
 
1. Medical support  
 
 secure the airways to protect aspiration 
 
 To lower the blood pressure  
 
 To reduce brain edema 
 
 To prevent hyperthermia 
 
 To control blood sugars 
 
 
2. Thrombolysis 
 
INDICATION 
 
CONTRAINDICATION 
 Clinical diagnosis of 
 
stroke 
 
 Onset of symptoms to the  
 
Time of drug administration 
  
 within 3 hours 
 
 
 CT scan showing no 
  
Hemorrhage or edema of  
 
>1/3 of MCA territory 
 
 Consent by patient or  
 
surrogate 
 Sustained BP 185/110 mm  
 
Hg despite treatment 
 
 Platelet < 1,00,000 ,     
 
HCT<25%,  
 
 Blood glucose <50 or  
 
>400g/dl 
 
 Use of heparin within 48 
  
hours and 
 
 Prolonged PTT and elevated 
 
 INR 
 
 Rapidly improving symptoms 
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 Prior stroke or head injury 
  within 3months, prior intracranial  
 
hemorrhage  
 
 
 Patients undergone surgery  
 
within2 weeks 
 
 Symptoms of mild stroke 
 
 Any bleeding from GIT  
 
within 2 weeks deeply  
 
 Comatose and stuporous  
 Patients suffered from recent 
myocardial infarction. 
 
IV rtPA 0.9mg/kg 10% given as bolus and remaining within 1hour 
 
3. Antiplatelets – Aspirin or clopilet or combination of aspirin and  
 
dipyridamole 
 
4. Anticoagulation – Indicated in conditions like carotid artery  
 
dissection, basilar artery thrombosis , cardio embolic stroke. 
 
5. Neuro protection 
  
6. Stroke centres and rehabilitation 
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       THE PROGNOSIS OF ACUTE STROKE 
 
The outcome of patients  recovered from stroke depends on certain factors 
 
1. Age : 
 
Survival is better in younger than the older people,  
 
 Better in men than in women 
 
2.Comorbid conditions: 
 
Leads to recurrent stroke and also influence on outcome and survival of  
 
the individual 
 
A. Diabetes, 
 
B. Dyslipidemia, 
 
C. Hypertension,  
 
D. Atrial fibrillation, 
 
E. Smoking, alcohol, 
 
F. Previous h/o stroke 
 
 Diseases such as  
 
A. COPD, 
 
B. Parkinsons disease, 
 
C. Peripheral vascular disease, 
 
D. Polyneuropathy 
 
have effect on functional recovery. 
 
 
 
 
 
                                            
50 
 
 
 
3. Lesion related factors 
 
Survival is poor in anterior circulation infarcts than ICH or SAH 
 
High risk of mortality 
 
A. Coma at onset of stroke 
 
B. Seizures 
 
C. Brain stem dysfunction 
 
D. B/L pyramidal signs  
 
 
4.  Specific therapy 
 
Good  cardiac and respiratory support  may reduce the mortality. 
 
5.  Biochemical factors: 
 
Factors associated with poor outcome are 
 
A. Micro albuminuria  
 
B. . Lipoprotein (a)  
 
C. Higher blood glucose at the onset of stroke even in non diabetic individual 
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STROKE SCALES 
 
Acute assessment stroke scales 
 
1. Canadian neurological scale 
 
2. European stroke scale 
 
3. Glasgow coma scale 
 
4. Hemispheric stroke scale 
 
5. National institute of health stroke scale 
 
 
Functional assessment scale 
 
1. Modified Rankins scale 
 
2. Barthel index 
 
3. Glasgow outcome scale 
 
4. Berg balance 
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   NATIONAL INSTITUTES OF HEALTH STROKESCALE 
 
LEVEL                                                                                SCORE 
 
Stages of consciousness 
 
Conscious                                                                         0 point 
 
Somnolent                                                                        1 point 
 
Patient responds to deep painful stimuli                          2 points 
 
Deeply comatose                                                              3 points 
 
Orientatation 
 
Tells about his age and date                                             0 point 
 
Able to answer one question perfectly                             1 point 
 
Not able to answer any question properly                        2 points 
 
Response to verbal 
 
Obeys 2 verbal speech                                                         0 point 
 
Obeys 1 verbal speech                                                         1 point 
 
Not obeying to any verbal speech                                        2 points 
 
Movement of eyes 
  
Perfect movement of both the eyes                                      0 point 
 
Moderate paresis to 1 one side                                            1 point 
 
Severe gaze palsy to 1 side                                                  2 points 
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Visual impairment 
 
Normal vision                                                                        0 point 
 
Homonymous hemianopia (moderate)                                  1 point 
 
Homonymous hemianopia (total)                                          2 points 
 
Total visual impairment                                                         3 points 
 
Motor function ( face) 
 
Normal face                                                                           0 point 
 
Minimal one sided facial palsy                                              1 point 
 
Moderate one sided facial palsy                                            2 points 
 
Total facial palsy either 1 or 2 sides                                      3 points 
 
Motor function of the upper limb ( scores 8 points) 
 
No paralysis                                                                          0 point 
 
Slight decrease in movement in upper limb                         1 point 
 
Minimal strength against gravity                                          2 points 
 
Moderate strength against gravity but moves limbs             3 points 
 
Complete paralysis                                                                4 points 
 
Motor function of the lower limbs ( score 8 points) 
 
No paralysis                                                                          0 point 
 
Slight paralysis of lower limb                                               1 point 
 
Moderate paralysis against gravity                                       2 points 
 
Moderate strength against gravity but moves the limb         3 points 
 
Complete paralysis                                                                4 points 
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Ataxia of limb ( not in presence of paralysis) 
 
Normal ataxia                                                                                 0 point 
 
Present in 1 limb                                                                            1 point 
 
Present in 2 limbs                                                                           2 points 
 
Sensory modalities 
 
Normal                                                                                           0 point 
 
Sensory loss from minimal to moderate                                        1 point 
 
Sensory loss is complete                                                                2 points 
 
Speech 
 
Speech is normal                                                                           0 point 
 
Minimal to moderate speech impairment                                     1 point 
 
Speech impairment is severe                                                        2 points 
 
Speech loss is complete                                                                3 points 
 
Articulation 
 
Normal                                                                                          0 point 
 
Minimal to moderate articulation impairment                              1 point 
 
Severe articulation impairment                                                     2 points 
 
Neglect 
 
Normal                                                                                          0 point 
 
Minimal to moderate visual or sensory neglect                            1 point 
 
Severe visual and sensory neglect                                                2 points      
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MODIFIED RANKINS SCALE 
 
SCORE SEVERITY OF FUNCTIONAL LOSS 
 
1-  normal 
 
2-  symptoms present but no impairment 
 
3-  minimal impairment with no assistance required 
 
4-  impairment is moderate but can move 
 
5-  severe impairment 
 
6-  expired 
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COMPLICATIONS OF STROKE  
Neurological 
o Recurrent stroke  
o Epileptic seizure  
 Infections 
o Urinary tract infection,  
o Chest infection  
o Others  
 Mobility related 
o Falls  
o Falls with serious injury  
o Pressure sores  
 Thromboembolism 
o Deep venous thrombosis  
o Pulmonary embolism 
 Pain 
o Shoulder pain  
 o Other pain  
 Psychological 
o Depression  
o Anxiety  
o Emotionalism  
o Confusion  
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                                              MICRO ALBUMINURIA 
 
               Micro albuminuria is defined as urine excretion of albumin of 20- 
200mcg/min or 30-300 mg/24 hrs 
 
MECHANISM 
                Micro albuminuria is associated with vascular permeability. Any 
 small changes in vessels gets amplified by kidney. Kidney receive quarter of  
cardiac output. The amount of albumin entering kidney is 70 kgs. The  
glomerular filtrate  is 7g/24hrs. Most of the albumin is reabsorbed by  
proximal tubule leading to 10-30mg/24hrs of albumin in urine. The  
amount of albumin filtered over 24hrs is 7g. If 1% change in the systemic  
vascular permeability due to inflammation , extra 70mg of albumin will  
be filtered and albumin excretion will become more than 100mg per hour. 
Other mechanisms of  micro albuminuria are 
1. Impaired arterial dilatory capacity 
 
2. Hyper homocysteinemia 
 
3. Systemic trans vascular albumin leakage 
 
4. Hyper insulinemia 
 
5. Increased serum sialic acid 
 
6. Elevated vwf concentrates and pro thrombotic factors 
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               SIGNIFICANCE OF MICRO ALBUMINURIA 
 
              Micro albuminuria indicates increased vascular permeability  
 
and so its diagnosis shows not only renal disease but also higher risk  
 
of cerebrovascular diseases. 
 
            There are several studies that has been done and proved  
 
association of ischemic stroke and micro albuminuria 
 
1. DAMSGAARD EM et al follow 216 patients selected as control  
 
subjects for diabetes during the screening for diabetes mellitus  
 
among patient aged between 60-75 years in Denmark between feb 
                     1981 and 1987. Their examination showed median urinary  
excretion rate of albumin 8mcg/min. 8 of those below the median 
 
 died whereas 23 above the median died and the main cause of  
 
death was cardiovascular disease. 
 
 
2. YUDHKIN et al used Islington diabetes survey in 1988 and  
 
showed that there was significant correlation between albumin  
 
excretion rate and BP, blood sugar but not with age, sex or BMI. 
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3. MLCKB et al studied the frequency of micro albuminuria in  
 
patients with or without diabetes in Slovenia between 1994 and  
 
1998. They showed albuminuria was high in diabetes ,  
 
hypertension, dyslipidemia and PVDs. 
 
 
4. HEIKKE MEIETTINEN et al during 1982 to 1990 showed that  
 
increased excretion of urinary albumin in 25% non diabetes and  
 
58% diabetics. 
 
 
5. A F Muhammed found that micro albuminuria was 3 times high in  
 
patients with acute ischemic CVA than healthy individuals. On  
 
follow up, healthy patients with micro albuminuria had 32%  
 
increased  risk of vascular events. 
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6. YUYUN MF et al studied 23630 subjects between 40 to 79 years  
 
and followed them for 7 years. There were 246 strokes. He also 
  
found that in patients with micro albuminuria , there was 50 %  
 
increased risk of stroke. Thereby associating micro albuminuria 
  
independently with stroke. 
 
 
7. HANS L HILLEGE et al studied micro albuminuria in  
 
 Netherlands  in 2001 and  showed that  micro albuminuria is 
  
associated with cardiovascular risk factors. 
 
 
8. TURAJ et al studied 52 patients in Poland within 24 hours of  
 
stroke . Micro albuminuria was found in 24 out of 52 stroke patients  
 
and 5 out of 37 controls, p<0.05.  Also 3 months mortality was 
 
 higher in patients with micro albuminuria than without, thus  
 
proving the fact that micro albuminuria is an independent risk factor  
 
for ischemic stroke and also is a prognostic marker.  
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9.  J Chowdhury studied 82 people between 45-70 years . 86% of MA +ve,  
 
and 63% MA –ve group . 63.3% are males and 36% were females in  
 
MA +ve group. 13.3% are females and 86.7% are males in MA –ve  
 
group. The mean age and sex differences between patients in both  
 
groups were not significant. According to that study, mortality rate in  
 
MA +ve group was 26.7% and that of MA –ve group is 11.7%. So  
 
Micro albuminuria associated with higher mortality. 
 
 
10.   Ghosh et al made a group of 83 and acute ischemic stroke  
 
patients(who were not diabetic) were included. Two more groups were  
 
formed .One group by 60 healthy individuals whose age, sex were 
 
 matched and other group by 70 patients who had chronic neurological 
 
 disease. On day 1,4,7 spot urinary albumin creatinine ratio in first  
 
morning sample was measured. 61.79% with acute ischemic stroke  
 
were MA +ve on day 1 .Only 13% in non stroke neurological patients 
 
 and  only 7% in healthy controls. Patients with MA has 25-45% (high)  
 
14 day disease mortality. Patients without stroke has only 5.88%  
 
mortality. Thus micro albuminuria  associated with  acute ischemic  
 
stroke and also high disease mortality. 
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11.  Klausen studied timed overnight sample of urine  collected from 491  
woman and men with coronary artery disease. 141 patients in that group  
died during the follow up period. The death risk associated with MA were  
100% high . Thus proving micro albuminuria  is associated with 
 increased mortality in patients with cardiovascular diseases 
 
12. Gumbnger et al studied the potential of micro albuminuria as a  
 
prognostic marker in  acute ischemic stroke . And concluded that \ 
 
micro albuminuria is a good predictor of poor outcome. 
 
 
13. Lee et al.in his study gave a conclusion that micro albuminuria  has a  
 
independent and strong association with stroke . 
 
 
14.  Meng Lee, Jeffrey L Saver et al, did a meta analysis in Los Angeles,  
 
they took 12 studies, with total of 48,598 participants 1263 stroke 
 
 incidents. They  concluded that  micro albuminuria was associated  
 
with higher risk of stroke  even after adjustment for cardiovascular  
 
risk factors . 
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15. Nancy Beamer, Bruce M Coull, Wayne M Clarke, Mike Wynn did a 
 
 study in Portland in 1999.They  found out that micro albuminuria was 3 
  
times  prevalent  in patients with recent stroke. The prevalence of 
  
micro albuminuria was high in all  ischemic stroke subtypes like  
 
athero embolic, thrombotic and lacunar. Thus  Micro albuminuria was  
 
an independent significant risk factor of future stroke. 
16. .Farooq et al did a cross sectional study in 2009 to determine the  
 
frequency of micro albuminuria in patient with ischemic stroke. Out of  
 
the 195 patients of ischemic stroke  micro albuminuria was present in 94  
 
and absent in 101. 
 
 
17.  Dirk Sander et  found that micro albuminuria is associatied with  
 
increase in thickness of intima and media of blood vessel wall,  
 
peripheral vascular disease, decrease in ankle brachial index. 
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18.  Nidhinandana et al did a study during  2008. He found  the association  
 
between risk factors for ischemic stroke in  patients and concluded that  
 
diabetic mellitus and hypertension are one of the important factor for  
 
ischemic stroke. The diabetes and hypertension were  associated with 
 
 micro albuminuria.  
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METHODS TO DETECT MICRO ALBUMINURIA 
1. Dipstick method 
 
2. Semi quantitative analysis 
 
3. Chemical precipitation tests 
 
4. Quantitative analysis like radioimmunoassay 
 
TREATMENT FOR MICRO ALBUMINURIA 
1. Control of hypertension- drug of choice – ACE I , ARB 
 
2. Control of blood glucose 
 
3. Treatment of hyperlipidemia 
 
4. Protein restriction 
 
5. Cessation of smoking. 
 
6. Drug effective in lowering micro albuminuria – ACE I, ARB, perindopril – 
indapamide . 
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                                              METHODOLOGY 
SOURCE OF DATA 
          The patients admitted in the department of Rajiv Gandhi Government  
General Hospital affiliated to Madras Medical College between Jan 2018 to  
JUNE 2018 were taken in our study. The ethical committee approval was  
obtained. There were 50 patients enrolled , diagnosed clinically ,confirmed by  
CT brain. 
          Cases : 50 patients diagnosed to have ischemic stroke by clinical methods and  
 by ct  brain  presenting within 48 hrs and who are non- diabetic 
          Controls :50  Age and sex matched individuals  who are non- diabetic and have  
not suffered from ischemic stroke 
 
STUDY DESIGN 
It was a prospective observational study. 
 
INCLUSION CRITERIA 
1. The patients diagnosed as stroke according to WHO criteria within 48 
 
 hours of onset 
 
2. Confirmed by CT 
 
3. Consent obtained from the patient. 
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EXCLUSION CRITERIA 
1. The patients with hemorrhagic stroke  
 
2. Recurrent CVA 
 
3. Diabetes mellitus 
 
4. Kidney diseases and non nephrotoxic drugs 
 
5. Liver diseases 
 
6. Chronic inflammatory conditions 
 
7. Connective tissue disorders 
 
8. Neoplasms 
 
9. On immunosuppressant therapy 
 
10.  Fever or foci of acute infect 
 
INVESTIGATIONS 
 
1. Renal function test 
 
2. Liver function test 
 
3. Serum electrolytes 
 
4. Fasting lipid profiles 
 
5.  Random blood sugar 
 
6. Spot urine albumin creatinine ratio 
 
7. CT Brain 
 
                   
                                            
                                   RESULTS  AND  OBSERVATIONS
Table 1a  - Age distribution
Age in 
years 
Cases  
  
N 
<40 years 10 
41-60 
years 
22 
>60 years 18 
total 50 
Pearson chi square = 3.170 p=0.20
 
 
1) p value is 0.20 
 
2) Inference :  There is no statistically significant difference  in age 
 
distribution in cases and controls
 
 
0%
20%
40%
60%
80%
100%
68 
 
 
 in cases and controls 
Controls 
% N % 
20% 5 
44% 30 
36% 15 
100% 50 100%
 
 
cases
controls
20%
10%
44%
60%
36%
30%
<40 years 41-60 years >60 years
10% 
60% 
30% 
 
 
 
                                            
 
 
Table 1.b. Age distribution and 
 
Age 
distribution 
Urine  
albumin levels
<20 
N 
<40 years 
41-60 years 
>60 years 
total 
Chi square= 3.18182   p=0.20374
 
 
 
1) P value is 0.20374 
 
2) Inference : Age distribution  is not sta
 
urine albumin levels
 
 
 
 
0%
10%
20%
30%
40%
50%
60%
70%
Albumin levels <20 
10%
69 
 
 urine albumin levels 
 
Urine Urine  
albumin levels 
20-200 
% N % 
1 10% 9 
3 30% 19 
6 60% 12 
10 100% 40 
 
tistically significantly associated with 
 
Albumin levels 2
23%
30%
48%
60%
30%
<40 years 41-60 years >60 years
23% 
48% 
30% 
100% 
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Table 2.a Sex distribution in cases and controls 
 
Sex 
distribution 
Cases  
  
Controls 
N % N % 
Male  30 60% 32 64% 
Female 20 40% 18 36% 
Total 50 100% 50 100% 
Pearson chi square = 0.170 p=0.680 
 
 
1) p value is  0.680 
 
2) Inference : There is no statistically significance  difference in sex  
 
distribution in case and controls 
 
 
 
 
 
 
60%
64%
40%
36%
0% 10% 20% 30% 40% 50% 60% 70%
cases
controls
Female Male 
                                            
 
Table 2b – Sex distribution and 
 
Sex 
distribution 
Urine Urine 
<20 
N 
Male 
Female 
total 
Chi square =0.0229779 p=0.879514
 
1. P value is 0.879514 
 
2. Inference : Sex distribution has no statistically significant association with 
 
Urine albumin level 
 
 
 
0%
20%
40%
60%
80%
100%
<20 (Albumin levels)
71 
 
 urine albumin levels 
albumin levels Urine albumin levels
20-200 
% N % 
7 70% 27 
3 30% 13 
10 100% 40 
 
20-200 (Albumin levels)
70%
68%
30%
32%
Male Female
 
67.5% 
32.5% 
100% 
 
 
                                            
Table 3 – Duration of symptoms in hours
 
Duration of symptoms in 
hours 
<8 
9-24 
24-48 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
30%
Duration of symptoms in hours
72 
 
 
Number of cases  
3 6% 
32 64% 
15 30% 
6%
64%
 
<8
8 to 24
24-48
                                            
Table 4 – Symptoms 
 
Symptoms <20 (Urine 
Urine urine 
albumin 
levels) 
N 
LOC 0
Hemiplegia 10
Aphasia 6
Seizures 0
 
   
1) Severe symptoms like loss of co
 
with micro albuminuria
 
 
2) Inference : Micro albuminuria correlates with severity of stroke
 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
LOC Hemiplegia
0%
23%
100%
77%
73 
 
  
20-200(Urine 
Urine urine 
albumin levels) 
   
% N % Total
 0% 6 100% 
 23% 34 77% 
 30% 14 70% 
 0% 6 100% 
nsciousness and seizures were 100% associated 
 
Aphasia Seizures
30%
0%
70%
100% 20-200(Albumin levels)
<20 (Albumin levels)
 
16 
44 
20 
6 
 
 
 
                                            
 
 
Paucity of movements
Left 
Right 
None 
Pearson chi square =2.917  p=0.233
 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
<20
40%
60%
0%
74 
 
Table 5 – Paucity of movements 
  Urine 
albumin 
levels<20 
Urine  
albumin levels 
20-200 
N % N % 
4 40% 20 50% 
6 60% 14 35% 
0 0% 6 15% 
 
 
20-200
50%
35%
15%
total 
24 
20 
6 
 
None
Right
Left
                                            
     Table 6 – Micro albuminuria in cases and control
 
Urine albumin 
levels 
Case 
N 
<20 10 
20-200 40 
total 50 
Pearson chi square =50.505** 
 
1. Pvalue is < 0.001 
 
2. Inference : Micro albuminuria is a risk factor for stroke
 
0%
20%
40%
60%
80%
100%
75 
 
 
Control 
% N % 
20% 35 
80% 15 
100% 50 
 p<0.001 
 
 
Case
Control
20%
70%
80%
30%
<20 20-200
70% 
30% 
100% 
 
                                            
Table 7 – Risk factors 
 
Risk factor <20 (Urine 
N 
Smoking(20) 10 
Alcohol(25) 10 
total 20 
Pearson chi square =0.450 
 
1. Pvalue  is 0.5020 
 
2. Inference : Smoking and alcohol  is not statistically significa
 
with micro albuminuria
 
0%
20%
40%
60%
80%
100%
76 
 
albumin levels) 20- 200 (Urine albumin 
levels) 
% N % 
50% 10 
40% 15 
44% 25 
 p=0.5020.001 
ntly associated 
 
 
Case
Control
50%
50%
40%
60%
Smoking Alcohol
50% 
60% 
66% 
 
 
                                            
 
Table 8 – Fasting lipid profile
 
Total Cholesterol 
HDL 
LDL 
Triglyceride 
p>0.05 
 
1. P value is >0.05 
 
2. Inference :  Lipid profile has no 
 
Micro albuminuria 
 
 
 
 
 
 
0
20
40
60
80
100
120
140
160
180
200
Total Cholesterol
196.4 194.6
<20 (Albumin levels)
77 
 
 
<20 ( Urine albumin levels) 
Mean cholesterol 
20-200 (
levels) 
Mean cholesterol
196.4  194.6 
45.3 45.2 
105.5 110.1 
198.7 196.5 
statistically  significant association with 
HDL LDL
45.3
105.5
198.7
45.2
110.1
20-200 (Albumin levels)
Urine albumin 
 
 
 
196.5
                                            
 
 
Table 9 – Blood pressure 
 
BP 
Systolic 
Diastolic 
p>0.05 
 
 
1) P value is >0.05 
 
2) Inference : Blood pressure has no sta
 
Micro albuminuria 
 
 
 
 
 
0
20
40
60
80
100
120
140
160
180
Systolic
170
<20 (Albumin levels)
78 
 
<20(Urine albumin levels) 
 Mean BP 
20-200 (
levels) 
Mean BP
170 172.5 
100 96 
tistically  significant association with 
Diastolic
100
172.5
96
20-200 (Albumin levels)
Urine albumin 
 
 
 
                                            
 
Table 10 – CT findings 
 
  <20 Urine albu
CT Brain N %
RACA 
territory 
0 
LACA 
territory 
0 
RMCA 
territory 
4 
LMCA  
territory 
6 
RPCA 
territory 
0 
LPCA 
territory 
0 
Pearson chi square =2.917 p=0.405
1) P  value is 0.405 
 
2) Territory of stroke has no sta
 
Micro albuminuria 
 
3) Most commonly affected was right middle cerebral artery
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
RACA 
territory
LACA 
territory
0% 0%
79 
 
min levels 20-200 Urine albumin levels
 N % 
0% 0 0%
0% 0 0%
17% 20 83%
30% 14 70%
0% 3 100%
0% 3 100%
 
tistically  significant association with 
 
RMCA 
territory
LMCA  
territory
RPCA 
territory
LPCA 
territory
17%
30%
0% 0%
83%
70%
100% 100%
   
Total 
 0 
 0 
 24 
 20 
 3 
 3 
 
 
20-200
<20
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                                                    DISCUSSION 
1. Cases : 50 patients diagnosed to have ischemic stroke by clinical methods and  
 
by ct  brain  presenting within 48 hrs and are  non-diabetic 
 
2. Controls : Age and sex matched individuals  who are non-diabetic and have not  
 
suffered from stroke 
 
3. In comparing age distribution in case and controls  p value is 0.20. There is no  
 
statistically significant difference  in age distribution in cases and controls 
 
4. In comparing sex distribution in cases and controls p value is  0.680. There is  
 
no statistically significance  difference in sex distribution in case and  
 
controls 
 
5.  P value is 0.20374 in studying association between age distribution and  
 
urine albumin levels. Age distribution  is not statistically significantly  
 
associated with urine albumin levels. 
 
6. P value is 0.879514 in  studying association between sex distribution and  
 
urine albumin levels. Sex distribution has no statistically significant  
 
association with urine albumin levels. 
 
7. Severe symptoms like loss of consciousness and seizures were 100% associated  
 
with micro albuminuria. Micro albuminuria correlates with severity of   
 
stroke 
 
 
                                            
81 
 
 
8. In comparing albumin level among cases and control P value is   
 
 < 0.001. Micro albuminuria is a risk factor for stroke. 
 
 
9. P value  is 0.5020 in studying association between smoking, alcohol with 
  
urine albumin levels . Smoking and alcohol  is not statistically significantly 
 
 associated with micro albuminuria 
 
10. P value is >0.050 in studying association between  lipid profile and albumin  
 
levels.  Lipid profile has no statistically  significant association with 
  
micro albuminuria 
 
11. P value is >0.05 studying association between hypertension and urine  albumin  
 
Blood pressure has no statistically  significant association with 
 
 micro albuminuria. 
 
12. Points 9,10,11 prove that micro albuminuria is independently associated 
 
with stroke. Not  associated with other factors 
 
13. P  value is 0.405 in studying association between territory involved and  
 
urine albumin levels. Territory of stroke has no statistically  significant  
 
association with micro albuminuria. 
 
14. Most commonly affected was right middle cerebral artery 
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15. Out of 50 stroke patients 80% have micro albuminuria . 
 
16. Out of  55 patients who have micro albuminuria 40 patients 72.72% have  
 
stroke.  
 
17. Thus micro albumunria is an independent risk factor in acute non diabetic  
          ischemic stroke. 
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                                                  CONCLUSION 
 
 There are many studies that have documented micro albuminuria   as a  
risk factor for acute ischemic stroke. 
 In our studies too micro albuminuria   was found to be an independent risk  
factor in acute ischemic stroke. Also we found that micro albuminuria  was  
associated with severe disease. 
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                                                          PROFORMA 
 
Patient profile 
 
NAME:                                                                             OP/IP NO: 
 
AGE:                                                                                 DOA: 
 
SEX:                                                                                  DOD: 
 
OCCUPATION:  
 
ADDRESS: 
 
PRESENTING COMPLAINTS 
 
1. Paucity of movements of one side of the body 
 
Yes/No – 
 
Duration – 
 
2. Loss of consciousness 
 
Yes/No- 
 
Duration- 
 
3. Seizures 
 
Yes /No – 
 
Duration – 
 
Type – 
 
   4.Aphasia  
 
Yes /No – 
 
Duration – 
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PAST HISTORY 
 
Diabetes mellitus- 
 
HTN – 
 
Renal insufficiency- 
 
Liver disease- 
 
H/O vascular events- 
 
FAMILY HISTORY 
 
Diabetes mellitus- 
 
HTN 
 
Cerebrovascular  accidents- 
 
 PERSONAL HISTORY 
 
Appetite- 
 
Diet- 
 
Sleep- 
 
Bladder movement- 
 
Bowel movement- 
 
Smoking – 
 
Alcohol intake- 
 
OBSTETRIC HISTORY 
 
( In females) 
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GENERAL PHYSICAL EXAMINATION 
Built – poor/moderate/well 
Nourishment – poor/moderate/well 
Pallor- 
Icterus- 
Cyanosis 
Clubbing- 
Lymphadenopathy- 
Oral cavity- 
Oedema- 
Weight- 
Height- 
VITALS 
Pulse- 
B.P- 
JVP- 
RR- 
Temperature- 
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SYSTEMIC EXAMINATION 
CNS 
      Higher mental functions 
      Cranial nerve examination 
      Motor examination 
                 Tone  
                 Power 
                 Reflexes 
                 Babinski sign 
    Sensory examination 
    Cerebellar signs   
    Spinal examination 
    Meninges 
 
OTHER SYSTEMS 
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INVESTIGATIONS 
 
1. RFT : 
 
2. LFT : 
 
3. SERUM  ELECTROLYTES: 
 
4. FLP : 
 
5. RBS : 
 
6. ECG : 
 
10. CT BRAIN 
 
11. SPOT URINARY ACR : 
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                KEYWORDS 
 LOC – loss of consciousness 
SZS – seizures 
APH-  aphasia 
Alb- urine albumin levels 
Smo- smoking  
Alc- alcohol 
TC- total cholesterol 
UR- urea 
CR- creatinine 
Electro- electrolytes 
CTB – CT  Brain 
MA – Micro albuminuria 
N- Normal 
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